• 1
    Wang, H. and Clarke, S. H., Regulation of B-cell development by antibody specificity. Curr. Opin. Immunol. 2004. 16: 246250.
  • 2
    Kraus, M., Alimzhanov, M. B., Rajewsky, N. and Rajewsky, K., Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell 2004. 117: 787800.
  • 3
    Cancro, M. P. and Kearney, J. F., B-cell positive selection: road map to the primary repertoire? J. Immunol. 2004. 173: 1519.
  • 4
    Pillai, S., Cariappa, A. and Moran, S. T., Marginal zone B cells. Annu. Rev. Immunol. 2005. 23: 161196.
  • 5
    Monroe, J. G., ITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat. Rev. Immunol. 2006. 6: 283294.
  • 6
    Berland, R. and Wortis, H. H., Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 2002. 20: 253300.
  • 7
    Liu, Y. J. and Banchereau, J., Regulation of B-cell commitment to plasma cells or to memory B cells. Semin. Immunol. 1997. 9: 235240.
  • 8
    McHeyzer-Williams, M. G. and Ahmed, R., B-cell memory and the long-lived plasma cell. Curr. Opin. Immunol. 1999. 11: 172179.
  • 9
    Radbruch, A., Muehlinghaus, G., Luger, E. O., Inamine, A., Smith, K. G. C., Dörner, T. and Hiepe, F., Competence and competition: the challenge of becoming a long-lived plasma cell. Nat. Rev. Immunol. 2006. 6: 741750.
  • 10
    Oracki, S. A., Walker, J. A., Hibbs, M. L., Corcoran, L. M. and Tarlinton, D. M., Plasma cell development and survival. Immunol. Rev. 2010. 237: 140159.
  • 11
    Goodnow, C. C., Vinuesa, C. G., Randall, K. L., Mackay, F. and Brink, R., Control systems and decision making for antibody production. Nat. Immunol. 2010. 11: 681688.
  • 12
    Grandien, A., Modigliani, Y., Coutinho, A. and Andersson, J., Suppression of B-cell differentiation by ligation of membrane-bound IgM. Eur. J. Immunol. 1993. 23: 15611565.
  • 13
    Knödel, M., Kuss, A. W., Berberich, I. and Schimpl, A., Blimp-1 over-expression abrogates IL-4- and CD40-mediated suppression of terminal B-cell differentiation but arrests isotype switching. Eur. J. Immunol. 2001. 31: 19721980.
  • 14
    Rui, L., Vinuesa, C. G., Blasioli, J. and Goodnow, C. C., Resistance to CpG DNA-induced autoimmunity through tolerogenic B-cell antigen receptor ERK signaling. Nat. Immunol. 2003. 4: 594600.
  • 15
    Rui, L., Healy, J. I., Blasioli, J. and Goodnow, C. C., ERK signaling is a molecular switch integrating opposing inputs from B-cell receptor and T-cell cytokines to control TLR4-driven plasma cell differentiation. J. Immunol. 2006. 177: 53375346.
  • 16
    Caven, T. H., Sturgill, J. L. and Conrad, D. H., BCR ligation antagonizes the IL-21 enhancement of anti-CD40/IL-4 plasma cell differentiation and IgE production found in low density human B-cell cultures. Cell. Immunol. 2007. 247: 4958.
  • 17
    Randall, T. D., Heath, A. W., Santos-Argumedo, L., Howard, M. C., Weissman, I. L. and Lund, F. E., Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers. Immunity 1998. 8: 733742.
  • 18
    Satpathy, S., Shenoy, G. N., Kaw, S., Vaidya, T., Bal, V., Rath, S. and George, A., Inhibition of terminal differentiation of B cells mediated by CD27 and CD40 involves signaling through JNK. J. Immunol. 2010. 185: 64996507.
  • 19
    Paus, D., Phan, T. G., Chan, T. D., Gardam, S., Basten, A. and Brink, R., Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B-cell differentiation. J. Exp. Med. 2006. 203: 10811091.
  • 20
    Phan, T. G., Paus, D., Chan, T. D., Turner, M. L., Nutt, S. L., Basten, A. and Brink, R., High affinity germinal center B cells are actively selected into the plasma cell compartment. J. Exp. Med. 2006. 203: 24192424.
  • 21
    Tsubata, T., Molecular mechanisms for apoptosis induced by signaling through the B-cell antigen receptor. Int. Rev. Immunol. 2001. 20: 791803.
  • 22
    Casola, S., Otipoby, K. L., Alimzhanov, M., Humme, S., Uyttersprot, N., Kutok, J. L., Carroll, M. C. et al., B-cell receptor signal strength determines B-cell fate. Nat. Immunol. 2004. 5: 317327.
  • 23
    Caldwell, R. G., Wilson, J. B., Anderson, S. J. and Longnecker, R., Epstein-Barr virus LMP2A drives B-cell development and survival in the absence of normal B-cell receptor signals. Immunity 1998. 9: 405411.
  • 24
    Sirac, C., Carrion, C., Duchez, S., Comte, I. and Cogné, M., Light chain inclusion permits terminal B-cell differentiation and does not necessarily result in autoreactivity. Proc. Natl. Acad. Sci. USA 2006. 103: 77477752.
  • 25
    Sirac, C., Bridoux, F., Carrion, C., Devuyst, O., Fernandez, B., Goujon, J.-M., El Hamel, C. et al., Role of the monoclonal kappa chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome. Blood 2006. 108: 536543.
  • 26
    Agenès, F. and Freitas, A. A., Transfer of small resting B cells into immunodeficient hosts results in the selection of a self-renewing activated B-cell population. J. Exp. Med. 1999. 189: 319330.
  • 27
    Walter, J. E., Rucci, F., Patrizi, L., Recher, M., Regenass, S., Paganini, T., Keszei, M. et al., Expansion of immunoglobulin-secreting cells and defects in B-cell tolerance in Rag-dependent immunodeficiency. J. Exp. Med. 2010. 207: 15411554.
  • 28
    Jiang, Y., Hirose, S., Sanokawa-Akakura, R., Abe, M., Mi, X., Li, N., Miura, Y. et al., Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus. Int. Immunol. 1999. 11: 16851691.
  • 29
    Oliver, A. M., Martin, F. and Kearney, J. F., IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 1999. 162: 71987207.
  • 30
    Genestier, L., Taillardet, M., Mondiere, P., Gheit, H., Bella, C. and Defrance, T., TLR agonists selectively promote terminal plasma cell differentiation of B-cell subsets specialized in thymus-independent responses. J. Immunol. 2007. 178: 77797786.
  • 31
    Yamamoto, N., Takeshita, K., Shichijo, M., Kokubo, T., Sato, M., Nakashima, K., Ishimori, M. et al., The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide dihydrochloride (BAY 61–3606) blocks antigen-induced airway inflammation in rodents. J. Pharmacol. Exp. Ther. 2003. 306: 11741181.
  • 32
    Imai, T., Jiang, M., Chambon, P. and Metzger, D., Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes. Proc. Natl. Acad. Sci. USA 2001. 98: 224228.
  • 33
    Fairfax, K. A., Corcoran, L. M., Pridans, C., Huntington, N. D., Kallies, A., Nutt, S. L. and Tarlinton, D. M., Different kinetics of blimp-1 induction in B-cell subsets revealed by reporter gene. J. Immunol. 2007. 178: 41044111.
  • 34
    Pillai, S., Cariappa, A. and Moran, S. T., Positive selection and lineage commitment during peripheral B-lymphocyte development. Immunol. Rev. 2004. 197: 206218.
  • 35
    Wong, S.-C., Chew, W.-K., Tan, J. E.-L., Melendez, A. J., Francis, F. and Lam, K.-P., Peritoneal CD5+ B-1 cells have signaling properties similar to tolerant B cells. J. Biol. Chem. 2002. 277: 3070730715.
  • 36
    Yang, Y., Tung, J. W., Ghosn, E. E. B., Herzenberg, L. A. and Herzenberg, L. A., Division and differentiation of natural antibody-producing cells in mouse spleen. Proc. Natl. Acad. Sci. USA 2007. 104: 45424546.
  • 37
    Merchant, M., Caldwell, R. G. and Longnecker, R., The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. J. Virol. 2000. 74: 91159124.
  • 38
    Portis, T., Cooper, L., Dennis, P. and Longnecker, R., The LMP2A signalosome—a therapeutic target for Epstein-Barr virus latency and associated disease. Front. Biosci. 2002. 7: d414d426.
  • 39
    Portis, T. and Longnecker, R., Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway. Oncogene 2004. 23: 86198628.
  • 40
    Engels, N., Yigit, G., Emmerich, C. H., Czesnik, D., Schild, D. and Wienands, J., Epstein-Barr virus LMP2A signaling in statu nascendi mimics a B-cell antigen receptor-like activation signal. Cell Commun. Signal. 2012. 10: 9.
  • 41
    Merchant, M., Swart, R., Katzman, R. B., Ikeda, M., Ikeda, A., Longnecker, R., Dykstra, M. L. et al. The effects of the Epstein-Barr virus latent membrane protein 2A on B-cell function. Int. Rev. Immunol. 2001. 20: 805835.
  • 42
    Hermiston, M. L., Xu, Z. and Weiss, A., CD45: a critical regulator of signaling thresholds in immune cells. Annu. Rev. Immunol. 2003. 21: 107137.
  • 43
    Poe, J. C., Hasegawa, M. and Tedder, T. F., CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction. Int. Rev. Immunol. 2001. 20: 739762.
  • 44
    Tarlinton, D., Radbruch, A., Hiepe, F. and Dörner, T., Plasma cell differentiation and survival. Curr. Opin. Immunol. 2008. 20: 162169.
  • 45
    Bernasconi, N. L., Traggiai, E. and Lanzavecchia, A., Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002. 298: 21992202.
  • 46
    Thorley-Lawson, D. A., Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 2001. 1: 7582.
  • 47
    Merchant, M., Swart, R., Katzman, R. B., Ikeda, M., Ikeda, A., Longnecker, R., Dykstra, M. L. et al., The effects of the Epstein-Barr virus latent membrane protein 2A on B-cell function. Int. Rev. Immunol. 2001. 20: 805835.
  • 48
    Laichalk, L. L. and Thorley-Lawson, D. A., Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 2005. 79: 12961307.
  • 49
    Goldman, J. P., Blundell, M. P., Lopes, L., Kinnon, C., Di Santo, J. P. and Thrasher, A. J., Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br. J. Haematol. 1998. 103: 335342.